Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Olivier Rascol

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Chemicals & Drugs

Procedures

Concepts & Ideas

Anatomy

Living Beings

Rats

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Schapira A H; Agid Y; Barone P; Jenner P; Lemke M R; Poewe W; Rascol O; Reichmann H; Tolosa E
Perspectives on recent advances in the understanding and treatment of Parkinson's disease.
Olanow C Warren; Rascol Olivier; Hauser Robert; Feigin Paul D; Jankovic Joseph; Lang Anthony; Langston William; Melamed Eldad; Poewe Werner; Stocchi Fabrizio; Tolosa Eduardo;
A double-blind, delayed-start trial of rasagiline in Parkinson's disease.
Péran Patrice; Cardebat Dominique; Cherubini Andrea; Piras Fabrizio; Luccichenti Giacomo; Peppe Antonella; Caltagirone Carlo; Rascol Olivier; Démonet Jean-François; Sabatini Umberto
Object naming and action-verb generation in Parkinson's disease: a fMRI study.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Olivier Rascol (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Schapira A H; Agid Y; Barone P; Jenner P; Lemke M R; Poewe W; Rascol O; Reichmann H; Tolosa E
Perspectives on recent advances in the understanding and treatment of Parkinson's disease.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2009;16(10):1090-9.
2009: Olanow C Warren; Rascol Olivier; Hauser Robert; Feigin Paul D; Jankovic Joseph; Lang Anthony; Langston William; Melamed Eldad; Poewe Werner; Stocchi Fabrizio; Tolosa Eduardo;
A double-blind, delayed-start trial of rasagiline in Parkinson's disease.
The New England journal of medicine 2009;361(13):1268-78.
2009: Péran Patrice; Cardebat Dominique; Cherubini Andrea; Piras Fabrizio; Luccichenti Giacomo; Peppe Antonella; Caltagirone Carlo; Rascol Olivier; Démonet Jean-François; Sabatini Umberto
Object naming and action-verb generation in Parkinson's disease: a fMRI study.
Cortex; a journal devoted to the study of the nervous system and behavior 2009;45(8):960-71.
2009: Ory-Magne Fabienne; Brefel-Courbon Christine; Payoux Pierre; Debruxelles Sabrina; Sibon Igor; Goizet Cyril; Labauge Pierre; Menegon Patrice; Uro-Coste Emmanuelle; Ghetti Bernardino; Delisle Marie Bernadetle; Vidal Ruben; Rascol Olivier
Clinical phenotype and neuroimaging findings in a French family with hereditary ferritinopathy (FTL498-499InsTC).
Movement disorders : official journal of the Movement Disorder Society 2009;24(11):1676-83.
2009: Péran Patrice; Cherubini Andrea; Luccichenti Giacomo; Hagberg Gisela; Démonet Jean-François; Rascol Olivier; Celsis Pierre; Caltagirone Carlo; Spalletta Gianfranco; Sabatini Umberto
Volume and iron content in basal ganglia and thalamus.
Human brain mapping 2009;30(8):2667-75.
2009: Evatt Marian L; Chaudhuri K Ray; Chou Kelvin L; Cubo Ester; Hinson Vanessa; Kompoliti Katie; Yang Chengwu; Poewe Werner; Rascol Olivier; Sampaio Cristina; Stebbins Glenn T; Goetz Christopher G
Dysautonomia rating scales in Parkinson's disease: sialorrhea, dysphagia, and constipation--critique and recommendations by movement disorders task force on rating scales for Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2009;24(5):635-46.
2009: Petzold Axel; Thompson Edward J; Keir Geoffrey; Quinn Niall; Holmberg Bjorn; Dizdar Nil; Wenning Gregor K; Rascol Olivier; Tolosa Eduardo; Rosengren Lars
Longitudinal one-year study of levels and stoichiometry of neurofilament heavy and light chain concentrations in CSF in patients with multiple system atrophy.
Journal of the neurological sciences 2009;279(1-2):76-9.
2009: Grosset Donald; Antonini Angelo; Canesi Margherita; Pezzoli Gianni; Lees Andrew; Shaw Karen; Cubo Esther; Martinez-Martin Pablo; Rascol Olivier; Negre-Pages Laurence; Senard Ana; Schwarz Johannes; Strecker Karl; Reichmann Heinz; Storch Alexander; Löhle Matthias; Stocchi Fabrizio; Grosset Katherine
Adherence to antiparkinson medication in a multicenter European study.
Movement disorders : official journal of the Movement Disorder Society 2009;24(6):826-32.
2009: Giladi Nir; Tal Joseph; Azulay Tali; Rascol Oliver; Brooks David J; Melamed Eldad; Oertel Wolfgang; Poewe Werner H; Stocchi Fabrizio; Tolosa Eduardo
Validation of the freezing of gait questionnaire in patients with Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2009;24(5):655-61.
2009: Rascol Olivier; Perez-Lloret Santiago
Rotigotine transdermal delivery for the treatment of Parkinson's disease.
Expert opinion on pharmacotherapy 2009;10(4):677-91.
2009: Rascol Olivier
"Disease-modification" trials in Parkinson disease: target populations, endpoints and study design.
Neurology 2009;72(7 Suppl):S51-8.
2009: Chaumet Guillaume; Taillard Jacques; Sagaspe Patricia; Pagani Massimo; Dinges David F; Pavy-Le-Traon Anne; Bareille Marie-Pierre; Rascol Olivier; Philip Pierre
Confinement and sleep deprivation effects on propensity to take risks.
Aviation, space, and environmental medicine 2009;80(2):73-80.
2009: Payoux Pierre; Remy Philippe; Miloudi Malika; Houeto Jean-Luc; Stadler Claudio; Bejjani Boulos-Paul; Yelnik Jérome; Samson Yves; Rascol Olivier; Agid Yves; Damier Philippe
Contrasting changes in cortical activation induced by acute high-frequency stimulation within the globus pallidus in Parkinson's disease.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 2009;29(2):235-43.
2009: Hauser R A; Bronzova J; Sampaio C; Lang A E; Rascol O; Theeuwes A; van de Witte S V;
Safety and tolerability of pardoprunox, a new partial dopamine agonist, in a randomized, controlled study of patients with advanced Parkinson's disease.
European neurology 2009;62(1):40-8.
2008: Goetz Christopher G; Tilley Barbara C; Shaftman Stephanie R; Stebbins Glenn T; Fahn Stanley; Martinez-Martin Pablo; Poewe Werner; Sampaio Cristina; Stern Matthew B; Dodel Richard; Dubois Bruno; Holloway Robert; Jankovic Joseph; Kulisevsky Jaime; Lang Anthony E; Lees Andrew; Leurgans Sue; LeWitt Peter A; Nyenhuis David; Olanow C Warren; Rascol Olivier; Schrag Anette; Teresi Jeanne A; van Hilten Jacobus J; LaPelle Nancy;
Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results.
Movement disorders : official journal of the Movement Disorder Society 2008;23(15):2129-70.
2008: Olanow C Warren; Hauser Robert A; Jankovic Joseph; Langston William; Lang Anthony; Poewe Werner; Tolosa Eduardo; Stocchi Fabrizio; Melamed Eldad; Eyal Eli; Rascol Olivier
A randomized, double-blind, placebo-controlled, delayed start study to assess rasagiline as a disease modifying therapy in Parkinson's disease (the ADAGIO study): rationale, design, and baseline characteristics.
Movement disorders : official journal of the Movement Disorder Society 2008;23(15):2194-201.
2008: Leentjens Albert F G; Dujardin Kathy; Marsh Laura; Martinez-Martin Pablo; Richard Irene H; Starkstein Sergio E; Weintraub Daniel; Sampaio Christina; Poewe Werner; Rascol Oliver; Stebbins Glenn T; Goetz Christopher G
Anxiety rating scales in Parkinson's disease: critique and recommendations.
Movement disorders : official journal of the Movement Disorder Society 2008;23(14):2015-25.
2008: Leentjens Albert F G; Dujardin Kathy; Marsh Laura; Martinez-Martin Pablo; Richard Irene H; Starkstein Sergio E; Weintraub Daniel; Sampaio Cristina; Poewe Werner; Rascol Oliver; Stebbins Glenn T; Goetz Christopher G
Apathy and anhedonia rating scales in Parkinson's disease: critique and recommendations.
Movement disorders : official journal of the Movement Disorder Society 2008;23(14):2004-14.
2008: Nègre-Pagès Laurence; Regragui Wafa; Bouhassira Didier; Grandjean Héléne; Rascol Olivier;
Chronic pain in Parkinson's disease: the cross-sectional French DoPaMiP survey.
Movement disorders : official journal of the Movement Disorder Society 2008;23(10):1361-9.
2008: Rascol Olivier; Poewe Werner; Lees Andrew; Aristin Marina; Salin Laurence; Juhel Nolwenn; Waldhauser Lisa; Schindler Thomas;
Tesofensine (NS 2330), a monoamine reuptake inhibitor, in patients with advanced Parkinson disease and motor fluctuations: the ADVANS Study.
Archives of neurology 2008;65(5):577-83.
2008: Sharma J C; Ross I N; Rascol O; Brooks D
Relationship between weight, levodopa and dyskinesia: the significance of levodopa dose per kilogram body weight.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2008;15(5):493-6.
2008: Rascol O
[Treatments in the early stage of Parkinson disease]
Revue neurologique 2008;164 Spec No 2():F77-84.
2008: Goetz Christopher G; Laska Eugene; Hicking Christine; Damier Philippe; Müller Thomas; Nutt John; Warren Olanow C; Rascol Olivier; Russ Hermann
Placebo influences on dyskinesia in Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2008;23(5):700-7.
2008: Fernandez Hubert H; Aarsland Dag; Fénelon Gilles; Friedman Joseph H; Marsh Laura; Tröster Alexander I; Poewe Werner; Rascol Olivier; Sampaio Cristina; Stebbins Glenn T; Goetz Christopher G
Scales to assess psychosis in Parkinson's disease: Critique and recommendations.
Movement disorders : official journal of the Movement Disorder Society 2008;23(4):484-500.
2007: Hauser Robert A; Rascol Olivier; Korczyn Amos D; Jon Stoessl A; Watts Ray L; Poewe Werner; De Deyn Peter P; Lang Anthony E
Ten-year follow-up of Parkinson's disease patients randomized to initial therapy with ropinirole or levodopa.
Movement disorders : official journal of the Movement Disorder Society 2007;22(16):2409-17.
2007: Gerdelat-Mas A; Simonetta-Moreau M; Thalamas C; Ory-Magne F; Slaoui T; Rascol O; Brefel-Courbon C
Levodopa raises objective pain threshold in Parkinson's disease: a RIII reflex study.
Journal of neurology, neurosurgery, and psychiatry 2007;78(10):1140-2.
2007: Seppi Klaus; Rascol Olivier
Dementia with Lewy bodies and Parkinson disease with dementia: can MRI make the difference?
Neurology 2007;69(8):717-8.
2007: Ferreira Joaquim; Silva João Maia; Freire Rita; Pignatelli João; Guedes Leonor Correia; Feijó Alexandra; Rosa Mário Miguel; Coelho Miguel; Costa João; Noronha Ana; Hewett Russell; Gomes A Marques; de Castro J L Cirne; Rascol Olivier; Sampaio Cristina
Skin cancers and precancerous lesions in Parkinson's disease patients.
Movement disorders : official journal of the Movement Disorder Society 2007;22(10):1471-5.
2007: Ory-Magne Fabienne; Brefel-Courbon Christine; Simonetta-Moreau Marion; Fabre Nelly; Lotterie Jean Albert; Chaynes Patrick; Berry Isabelle; Lazorthes Yves; Rascol Olivier
Does ageing influence deep brain stimulation outcomes in Parkinson's disease?
Movement disorders : official journal of the Movement Disorder Society 2007;22(10):1457-63.
2007: Poewe Werner H; Rascol Olivier; Quinn Niall; Tolosa Eduardo; Oertel Wolfgang H; Martignoni Emilia; Rupp Markus; Boroojerdi Babak;
Efficacy of pramipexole and transdermal rotigotine in advanced Parkinson's disease: a double-blind, double-dummy, randomised controlled trial.
Lancet neurology 2007;6(6):513-20.
2007: Holmberg Björn; Johansson Jan-Ove; Poewe Werner; Wenning Gregor; Quinn Niall P; Mathias Chris; Tolosa Eduardo; Cardozo Adriana; Dizdar Nil; Rascol Olivier; Slaoui Tarik;
Safety and tolerability of growth hormone therapy in multiple system atrophy: a double-blind, placebo-controlled study.
Movement disorders : official journal of the Movement Disorder Society 2007;22(8):1138-44.
2007: Schrag Anette; Barone Paolo; Brown Richard G; Leentjens Albert F G; McDonald William M; Starkstein Sergio; Weintraub Daniel; Poewe Werner; Rascol Olivier; Sampaio Cristina; Stebbins Glenn T; Goetz Christopher G
Depression rating scales in Parkinson's disease: critique and recommendations.
Movement disorders : official journal of the Movement Disorder Society 2007;22(8):1077-92.
2007: Damier Philippe; Thobois Stéphane; Witjas Tatiana; Cuny Emmanuel; Derost Philippe; Raoul Sylvie; Mertens Patrick; Peragut Jean-Claude; Lemaire Jean-Jacques; Burbaud Pierre; Nguyen Jean-Michel; Llorca Pierre-Michel; Rascol Olivier;
Bilateral deep brain stimulation of the globus pallidus to treat tardive dyskinesia.
Archives of general psychiatry 2007;64(2):170-6.
2007: Slaoui T; Mas-Gerdelat A; Ory-Magne F; Rascol O; Brefel-Courbon C
[Levodopa modifies pain thresholds in Parkinson's disease patients]
Revue neurologique 2007;163(1):66-71.
2007: Goetz Christopher G; Fahn Stanley; Martinez-Martin Pablo; Poewe Werner; Sampaio Cristina; Stebbins Glenn T; Stern Matthew B; Tilley Barbara C; Dodel Richard; Dubois Bruno; Holloway Robert; Jankovic Joseph; Kulisevsky Jaime; Lang Anthony E; Lees Andrew; Leurgans Sue; LeWitt Peter A; Nyenhuis David; Olanow C Warren; Rascol Olivier; Schrag Anette; Teresi Jeanne A; Van Hilten Jacobus J; LaPelle Nancy
Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Process, format, and clinimetric testing plan.
Movement disorders : official journal of the Movement Disorder Society 2007;22(1):41-7.
2007: Goetz Christopher G; Damier Philippe; Hicking Christine; Laska Eugene; Müller Thomas; Olanow C Warren; Rascol Olivier; Russ Hermann
Sarizotan as a treatment for dyskinesias in Parkinson's disease: a double-blind placebo-controlled trial.
Movement disorders : official journal of the Movement Disorder Society 2007;22(2):179-86.
2007: Rascol Olivier; Slaoui Tarik; Regragui Wafa; Ory-Magne Fabiene; Brefel-Courbon Christine; Montastruc Jean-Louis
Dopamine agonists.
Handbook of clinical neurology / edited by P.J. Vinken and G.W. Bruyn 2007;84():73-92.
2006: Pavy-Le Traon Anne; Hughson Richard L; Thalamas Claire; Galitsky Monique; Fabre Nelly; Rascol Olivier; Senard Jean-Michel
Cerebral autoregulation is preserved in multiple system atrophy: A transcranial Doppler study.
Movement disorders : official journal of the Movement Disorder Society 2006;21(12):2122-6.
2006: Rascol Olivier; Dubois Bruno; Caldas Alexandre Castro; Senn Stephen; Del Signore Susanna; Lees Andrew;
Early piribedil monotherapy of Parkinson's disease: A planned seven-month report of the REGAIN study.
Movement disorders : official journal of the Movement Disorder Society 2006;21(12):2110-5.
2006: Horstink M; Tolosa E; Bonuccelli U; Deuschl G; Friedman A; Kanovsky P; Larsen J P; Lees A; Oertel W; Poewe W; Rascol O; Sampaio C;
Review of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies (EFNS) and the Movement Disorder Society-European Section (MDS-ES). Part II: late (complicated) Parkinson's disease.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2006;13(11):1186-202.
2006: Horstink M; Tolosa E; Bonuccelli U; Deuschl G; Friedman A; Kanovsky P; Larsen J P; Lees A; Oertel W; Poewe W; Rascol O; Sampaio C;
Review of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies and the Movement Disorder Society-European Section. Part I: early (uncomplicated) Parkinson's disease.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2006;13(11):1170-85.
2006: Tardy Jean; Pariente Jérémie; Leger Anne; Dechaumont-Palacin Sophie; Gerdelat Angélique; Guiraud Vincent; Conchou Fabrice; Albucher Jean-François; Marque Philippe; Franceries Xavier; Cognard Christophe; Rascol Olivier; Chollet François; Loubinoux Isabelle
Methylphenidate modulates cerebral post-stroke reorganization.
NeuroImage 2006;33(3):913-22.
2006: Rascol Olivier; Brooks David J; Korczyn Amos D; De Deyn Peter P; Clarke Carl E; Lang Anthony E; Abdalla Mona;
Development of dyskinesias in a 5-year trial of ropinirole and L-dopa.
Movement disorders : official journal of the Movement Disorder Society 2006;21(11):1844-50.
2006: Reichmann Heinz; Bilsing Anja; Ehret Reinhard; Greulich Wolfgang; Schulz Jörg B; Schwartz Andreas; Rascol Olivier
Ergoline and non-ergoline derivatives in the treatment of Parkinson's disease.
Journal of neurology 2006;253 Suppl 4():IV36-8.
2006: Jost Wolfgang H; Angersbach Dieter; Rascol Olivier
Clinical studies with ropinirole in Parkinson's disease and RLS.
Journal of neurology 2006;253 Suppl 4():IV16-21.
2006: Rascol Olivier
Defining a minimal clinically relevant difference for the unified Parkinson's rating scale: an important but still unmet need.
Movement disorders : official journal of the Movement Disorder Society 2006;21(8):1059-61.
2006: Ferreira J J; Desboeuf K; Galitzky M; Thalamas C; Brefel-Courbon C; Fabre N; Senard J-M; Montastruc J-L; Sampaio C; Rascol O
Sleep disruption, daytime somnolence and 'sleep attacks' in Parkinson's disease: a clinical survey in PD patients and age-matched healthy volunteers.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2006;13(3):209-14.
2006: Andrieu S; Rascol O; Lang T; Grandjean H; Vellas B
Disease modifying trials in Alzheimer disease: methodological and statistical issues.
The journal of nutrition, health & aging 2006;10(2):116-7.
2006: Montastruc Jean-Louis; Sommet Agnès; Olivier Pascale; Bagheri Haleh; Gony Mireille; Lapeyre-Mestre Maryse; Brefel-Courbon Christine; Ferreira Joachim; Schmitt Laurent; Senard Jean-Michel; Rascol Olivier
[Drugs, Parkinson's disease and parkinsonian syndroms: recent advances in pharmacovigilance]
Thérapie 2006;61(1):29-38.
2005: Brefel-Courbon Christine; Payoux Pierre; Thalamas Claire; Ory Fabienne; Quelven Isabelle; Chollet François; Montastruc Jean Louis; Rascol Olivier
Effect of levodopa on pain threshold in Parkinson's disease: a clinical and positron emission tomography study.
Movement disorders : official journal of the Movement Disorder Society 2005;20(12):1557-63.
2005: Geser F; Seppi K; Stampfer-Kountchev M; Köllensperger M; Diem A; Ndayisaba J P; Ostergaard K; Dupont E; Cardozo A; Tolosa E; Abele M; Dodel R; Klockgether T; Ghorayeb I; Yekhlef F; Tison F; Daniels C; Kopper F; Deuschl G; Coelho M; Ferreira J; Rosa M M; Sampaio C; Bozi M; Schrag A; Hooker J; Kim H; Scaravilli T; Mathias C J; Fowler C; Wood N; Quinn N; Widner H; Nilsson C F; Lindvall O; Schimke N; Eggert K M; Oertel W; del Sorbo F; Carella F; Albanese A; Pellecchia M T; Barone P; Djaldetti R; Meco G; Colosimo C; Gonzalez-Mandly A; Berciano J; Gurevich T; Giladi N; Galitzky M; Ory F; Rascol O; Kamm C; Buerk K; Maass S; Gasser T; Poewe W; Wenning G K;
The European Multiple System Atrophy-Study Group (EMSA-SG).
Journal of neural transmission (Vienna, Austria : 1996) 2005;112(12):1677-86.
2005: Rascol Olivier
Assessing the risk of a necessary harm: placebo surgery in Parkinson disease.
Neurology 2005;65(7):982-3.
2005: Rascol Olivier
Rasagiline in the pharmacotherapy of Parkinson's disease--a review.
Expert opinion on pharmacotherapy 2005;6(12):2061-75.
2005: Gerdelat-Mas A; Loubinoux I; Tombari D; Rascol O; Chollet F; Simonetta-Moreau M
Chronic administration of selective serotonin reuptake inhibitor (SSRI) paroxetine modulates human motor cortex excitability in healthy subjects.
NeuroImage 2005;27(2):314-22.
2005: Sommet Agnès; Azaïs-Vuillemin Cécile; Bagheri Haleh; Rascol Olivier; Montastruc Jean Louis
Trimetazidine: a new cause for drug-induced parkinsonism?
Movement disorders : official journal of the Movement Disorder Society 2005;20(8):1080-1.
2005: Loubinoux Isabelle; Tombari David; Pariente Jérémie; Gerdelat-Mas Angélique; Franceries Xavier; Cassol Emmanuelle; Rascol Olivier; Pastor Josette; Chollet François
Modulation of behavior and cortical motor activity in healthy subjects by a chronic administration of a serotonin enhancer.
NeuroImage 2005;27(2):299-313.
2005: Rascol Olivier
Transdermal delivery of dopaminergic agents.
Neurology 2005;65(2 Suppl 1):S1-2.
2005: Baba Yasuhiko; Tsuboi Yoshio; Baker Matthew C; Uitti Ryan J; Hutton Michael L; Dickson Dennis W; Farrer Matthew; Putzke John D; Woodruff Bryan K; Ghetti Bernardino; Murrell Jill R; Boeve Bradley F; Petersen Ronald C; Verpillat Patrice; Brice Alexis; Delisle Marie-Bernadette; Rascol Oliver; Arima Kunimasa; Dysken Maurice W; Yasuda Minoru; Kobayashi Tomonori; Sunohara Nobuhiko; Komure Osamu; Kuno Sadako; Sperfeld Anne D; Stoppe Gabriela; Kohlhase Jürgen; Pickering-Brown Stuart; Neary David; Bugiani Orso; Wszolek Zbigniew K
The effect of tau genotype on clinical features in FTDP-17.
Parkinsonism & related disorders 2005;11(4):205-8.
2005: Thalamas Claire; Rajman Iris; Kulisevsky Jaime; Lledó Alberto; Mackie Alison E; Blin Olivier; Gillespie Todd A; Seger Mary; Rascol Olivier
Pergolide: multiple-dose pharmacokinetics in patients with mild to moderate Parkinson disease.
Clinical neuropharmacology 2005;28(3):120-5.
2005: Goetz Christopher G; Poewe Werner; Rascol Olivier; Sampaio Cristina
Evidence-based medical review update: pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004.
Movement disorders : official journal of the Movement Disorder Society 2005;20(5):523-39.
2005: Rascol O; Brooks D J; Melamed E; Oertel W; Poewe W; Stocchi F; Tolosa E;
Rasagiline as an adjunct to levodopa in patients with Parkinson's disease and motor fluctuations (LARGO, Lasting effect in Adjunct therapy with Rasagiline Given Once daily, study): a randomised, double-blind, parallel-group trial.
Lancet 2005;365(9463):947-54.
2004: Rascol Olivier; Pathak Atul; Bagheri Haleh; Montastruc J-L
Dopaminagonists and fibrotic valvular heart disease: further considerations.
Movement disorders : official journal of the Movement Disorder Society 2004;19(12):1524-5.
2004: Wenning Gregor K; Tison François; Seppi Klaus; Sampaio Cristina; Diem Anja; Yekhlef Farid; Ghorayeb Imad; Ory Fabienne; Galitzky Monique; Scaravilli Tommaso; Bozi Maria; Colosimo Carlo; Gilman Sid; Shults Clifford W; Quinn Niall P; Rascol Olivier; Poewe Werner;
Development and validation of the Unified Multiple System Atrophy Rating Scale (UMSARS).
Movement disorders : official journal of the Movement Disorder Society 2004;19(12):1391-402.
2004: Goetz Christopher G; Poewe Werner; Rascol Olivier; Sampaio Cristina; Stebbins Glenn T; Counsell Carl; Giladi Nir; Holloway Robert G; Moore Charity G; Wenning Gregor K; Yahr Melvin D; Seidl Lisa;
Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations.
Movement disorders : official journal of the Movement Disorder Society 2004;19(9):1020-8.
2004: Zijlmans Jan C M; Debilly Berengere; Rascol Olivier; Lees Andrew J; Durif Franck
Safety of entacapone and apomorphine coadministration in levodopa-treated Parkinson's disease patients: pharmacokinetic and pharmacodynamic results of a multicenter, double-blind, placebo-controlled, cross-over study.
Movement disorders : official journal of the Movement Disorder Society 2004;19(9):1006-1011.
2004: Olanow C Warren; Agid Yves; Mizuno Yoshi; Albanese Alberto; Bonuccelli Ubaldo; Damier Philip; De Yebenes Justo; Gershanik Oscar; Guttman Mark; Grandas F; Hallett Mark; Hornykiewicz Ole; Jenner Peter; Katzenschlager R; Langston William J; LeWitt Peter; Melamed Eldad; Mena M A; Michel P P; Mytilineou Catherine; Obeso Jose A; Poewe Werner; Quinn Niall; Raisman-Vozari R; Rajput Ali H; Rascol Olivier; Sampaio Christina; Stocchi Fabrizio
Levodopa in the treatment of Parkinson's disease: current controversies.
Movement disorders : official journal of the Movement Disorder Society 2004;19(9):997-1005.
2004: Woodruff Bryan K; Baba Yasuhiko; Hutton Michael L; Wszolek Zbigniew K; Tsuboi Yoshio; Kobayashi Tomonori; Ghetti Bernardino; Arima Kunimasa; Yasuda Minoru; Rascol Olivier
Haplotype-phenotype correlations in kindreds with the N279K mutation in the tau gene.
Archives of neurology 2004;61(8):1327; author reply 1327.
2004: Payoux Pierre; Remy Philippe; Damier Philipe; Miloudi Malika; Loubinoux Isabelle; Pidoux Bernard; Gaura Véronique; Rascol Olivier; Samson Yves; Agid Yves
Subthalamic nucleus stimulation reduces abnormal motor cortical overactivity in Parkinson disease.
Archives of neurology 2004;61(8):1307-13.
2004: Rascol Olivier; Pathak Atul; Bagheri Haleh; Montastruc Jean-Louis
New concerns about old drugs: Valvular heart disease on ergot derivative dopamine agonists as an exemplary situation of pharmacovigilance.
Movement disorders : official journal of the Movement Disorder Society 2004;19(6):611-3.
2004: Angibaud Gilles; Gaultier Claude; Rascol Olivier
Atypical parkinsonism and Annonaceae consumption in New Caledonia.
Movement disorders : official journal of the Movement Disorder Society 2004;19(5):603-4.
2004: Pollak P; Tison F; Rascol O; Destée A; Péré J J; Senard J M; Durif F; Bourdeix I
Clozapine in drug induced psychosis in Parkinson's disease: a randomised, placebo controlled study with open follow up.
Journal of neurology, neurosurgery, and psychiatry 2004;75(5):689-95.
2004: Vidal R; Ghetti B; Takao M; Brefel-Courbon C; Uro-Coste E; Glazier B S; Siani V; Benson M D; Calvas P; Miravalle L; Rascol O; Delisle M B
Intracellular ferritin accumulation in neural and extraneural tissue characterizes a neurodegenerative disease associated with a mutation in the ferritin light polypeptide gene.
Journal of neuropathology and experimental neurology 2004;63(4):363-80.
2004: Olanow C Warren; Damier Philippe; Goetz Christopher G; Mueller Thomas; Nutt John; Rascol Olivier; Serbanescu Alexandru; Deckers Frieda; Russ Hermann
Multicenter, open-label, trial of sarizotan in Parkinson disease patients with levodopa-induced dyskinesias (the SPLENDID Study).
Clinical neuropharmacology 2004;27(2):58-62.
2004: Durif F; Debilly B; Galitzky M; Morand D; Viallet F; Borg M; Thobois S; Broussolle E; Rascol O
Clozapine improves dyskinesias in Parkinson disease: a double-blind, placebo-controlled study.
Neurology 2004;62(3):381-8.
2004: Payoux Pierre; Boulanouar Kader; Sarramon Christine; Fabre Nelly; Descombes Sylvie; Galitsky Monique; Thalamas Claire; Brefel-Courbon Christine; Sabatini Umberto; Manelfe Claude; Chollet François; Schmitt Laurent; Rascol Olivier
Cortical motor activation in akinetic schizophrenic patients: a pilot functional MRI study.
Movement disorders : official journal of the Movement Disorder Society 2004;19(1):83-90.
2003: Lohmann Ebba; Periquet Magali; Bonifati Vincenzo; Wood Nick W; De Michele Giuseppe; Bonnet Anne-Marie; Fraix Valérie; Broussolle Emmanuel; Horstink Martin W I M; Vidailhet Marie; Verpillat Patrice; Gasser Thomas; Nicholl David; Teive Hélio; Raskin Salmo; Rascol Olivier; Destée Alain; Ruberg Merle; Gasparini Francesca; Meco Giuseppe; Agid Yves; Durr Alexandra; Brice Alexis;
How much phenotypic variation can be attributed to parkin genotype?
Annals of neurology 2003;54(2):176-85.
2003: Courbon Frédéric; Brefel-Courbon Christine; Thalamas Claire; Alibelli Marie-Jeanne; Berry Isabelle; Montastruc Jean-Louis; Rascol Olivier; Senard Jean-Michel
Cardiac MIBG scintigraphy is a sensitive tool for detecting cardiac sympathetic denervation in Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2003;18(8):890-7.
2003: Whone Alan L; Watts Ray L; Stoessl A Jon; Davis Margaret; Reske Sven; Nahmias Claude; Lang Anthony E; Rascol Olivier; Ribeiro Maria J; Remy Philippe; Poewe Werner H; Hauser Robert A; Brooks David J;
Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL-PET study.
Annals of neurology 2003;54(1):93-101.
2003: Thobois Stéphane; Ribeiro Maria-Joao; Lohmann Ebba; Dürr Alexandra; Pollak Pierre; Rascol Olivier; Guillouet Stéphane; Chapoy Elizabeth; Costes Nicolas; Agid Yves; Remy Philippe; Brice Alexis; Broussolle Emmanuel;
Young-onset Parkinson disease with and without parkin gene mutations: a fluorodopa F 18 positron emission tomography study.
Archives of neurology 2003;60(5):713-8.
2003: Brefel-Courbon Christine; Desboeuf Karine; Thalamas Claire; Galitzky Monique; Senard Jean-Michel; Rascol Olivier; Montastruc Jean-Louis
Clinical and economic analysis of spa therapy in Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2003;18(5):578-84.
2003: Ziegler Marc; Castro-Caldas Alexandre; Del Signore Susanna; Rascol Olivier
Efficacy of piribedil as early combination to levodopa in patients with stable Parkinson's disease: a 6-month, randomized, placebo-controlled study.
Movement disorders : official journal of the Movement Disorder Society 2003;18(4):418-25.
2003: Rascol Olivier
Monoamine oxidase inhibitors--is it time to up the TEMPO?
Lancet neurology 2003;2(3):142-3.
2003: Vidal Ruben; Delisle Marie Bernadette; Rascol Olivier; Ghetti Bernardino
Hereditary ferritinopathy.
Journal of the neurological sciences 2003;207(1-2):110-1.
2003: Péran Patrice; Rascol Olivier; Démonet Jean-François; Celsis Pierre; Nespoulous Jean-Luc; Dubois Bruno; Cardebat Dominique
Deficit of verb generation in nondemented patients with Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2003;18(2):150-6.
2003: Cintas P; Simonetta-Moreau M; Ory F; Brefel-Courbon C; Fabre N; Chaynes P; Sabatier J; Sol J C; Rascol O; Berry I; Lazorthes Y
Deep brain stimulation for parkinson's disease: correlation between intraoperative subthalamic nucleus neurophysiology and most effective contacts.
Stereotactic and functional neurosurgery 2003;80(1-4):108-13.
2003: Rascol Olivier; Payoux Pierre; Ory Fabienne; Ferreira Joaquim J; Brefel-Courbon Christine; Montastruc Jean-Louis
Limitations of current Parkinson's disease therapy.
Annals of neurology 2003;53 Suppl 3():S3-12; discussion S12-5.
2003: Rascol Olivier; Brefel-Courbon C; Payoux P; Ferreira J
The management of patients with early Parkinson's disease.
Advances in neurology 2003;91():203-11.
2002: Rascol O; Ferreira J J; Payoux P; Brefel-Courbon Ch; Montastruc J L
[Management of levodopa-induced dyskinesia]
Revue neurologique 2002;158 Spec no 1():S117-24.
2002: Tsuboi Y; Baker M; Hutton M L; Uitti R J; Rascol O; Delisle M-B; Soulages X; Murrell J R; Ghetti B; Yasuda M; Komure O; Kuno S; Arima K; Sunohara N; Kobayashi T; Mizuno Y; Wszolek Z K
Clinical and genetic studies of families with the tau N279K mutation (FTDP-17).
Neurology 2002;59(11):1791-3.
2002: Rascol O; Payoux P; Ferreira J; Brefel-Courbon C
The management of patients with early Parkinson's disease.
Parkinsonism & related disorders 2002;9(1):61-7.
2002: Simonetta Moreau M; Meunier S; Vidailhet M; Pol S; Galitzky M; Rascol O
Transmission of group II heteronymous pathways is enhanced in rigid lower limb of de novo patients with Parkinson's disease.
Brain : a journal of neurology 2002;125(Pt 9):2125-33.
2002: Tsuboi Yoshio; Uitti Ryan J; Delisle Marie-Bernadette; Ferreira Joaquim J; Brefel-Courbon Christine; Rascol Olivier; Ghetti Bernardino; Murrell Jill R; Hutton Michael; Baker Matthew; Wszolek Zbigniew K
Clinical features and disease haplotypes of individuals with the N279K tau gene mutation: a comparison of the pallidopontonigral degeneration kindred and a French family.
Archives of neurology 2002;59(6):943-50.
2002: Rascol Olivier; Goetz Christopher; Koller William; Poewe Werner; Sampaio Cristina
Treatment interventions for Parkinson's disease: an evidence based assessment.
Lancet 2002;359(9317):1589-98.
2002: Ferreira J J; Galitzky M; Thalamas C; Tiberge M; Montastruc J L; Sampaio C; Rascol O
Effect of ropinirole on sleep onset: a randomized, placebo-controlled study in healthy volunteers.
Neurology 2002;58(3):460-2.
2002: Naiglin L; Gazagne C; Dallongeville F; Thalamas C; Idder A; Rascol O; Malecaze F; Calvas P
A genome wide scan for familial high myopia suggests a novel locus on chromosome 7q36.
Journal of medical genetics 2002;39(2):118-24.
2002: Loubinoux Isabelle; Pariente Jérémie; Boulanouar Kader; Carel Christophe; Manelfe Claude; Rascol Olivier; Celsis Pierre; Chollet François
A single dose of the serotonin neurotransmission agonist paroxetine enhances motor output: double-blind, placebo-controlled, fMRI study in healthy subjects.
NeuroImage 2002;15(1):26-36.
2002: Loubinoux Isabelle; Pariente Jérémie; Rascol Olivier; Celsis Pierre; Chollet François
Selective serotonin reuptake inhibitor paroxetine modulates motor behavior through practice. A double-blind, placebo-controlled, multi-dose study in healthy subjects.
Neuropsychologia 2002;40(11):1815-21.
2001: Pariente J; Loubinoux I; Carel C; Albucher J F; Leger A; Manelfe C; Rascol O; Chollet F
Fluoxetine modulates motor performance and cerebral activation of patients recovering from stroke.
Annals of neurology 2001;50(6):718-29.
2001: Rascol O; Fabre N
Dyskinesia: L-dopa-induced and tardive dyskinesia.
Clinical neuropharmacology 2001;24(6):313-23.
2001: Rascol O; Ferreira J; Montastruc J L
[Abnormal diurnal somnolence, "sleep attacks" and antiparkinson drugs]
Revue neurologique 2001;157(10):1313-23.
2001: Chollet F; Loubinoux I; Pariente J; Carel C; Albucher J F; Rascol O; Guiraud-Chaumeil B
[Pharmacologic modification of cerebral activity: value of functional neuroimaging]
Revue neurologique 2001;157(8-9 Pt 1):827-31.
2001: Montastruc J L; Rascol O
Modafinil and pramipexole-associated somnolence.
Movement disorders : official journal of the Movement Disorder Society 2001;16(4):783-4.
2001: Rascol O; Arnulf I; Peyro-Saint Paul H; Brefel-Courbon C; Vidailhet M; Thalamas C; Bonnet A M; Descombes S; Bejjani B; Fabre N; Montastruc J L; Agid Y
Idazoxan, an alpha-2 antagonist, and L-DOPA-induced dyskinesias in patients with Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2001;16(4):708-13.
2001: Arnulf I; Vidailhet M; Bonnet A M; Descombes S; Jaillon C; Agid Y; Brefel C; Rascol O; Xie J; Pollak P; Cattelin F
Blockade of cholecystokinin-A receptors has no effect on dyskinesias in Parkinson's disease.
Journal of neurology, neurosurgery, and psychiatry 2001;70(6):812-3.
2001: Ferreira J J; Thalamas C; Montastruc J L; Castro-Caldas A; Rascol O
Levodopa monotherapy can induce "sleep attacks" in Parkinson's disease patients.
Journal of neurology 2001;248(5):426-7.
2001: Montastruc J L; Desboeuf K; Lapeyre-Mestre M; Senard J M; Rascol O; Brefel-Courbon C
Long-term mortality results of the randomized controlled study comparing bromocriptine to which levodopa was later added with levodopa alone in previously untreated patients with Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2001;16(3):511-4.
2001: Montastruc J L; Brefel-Courbon C; Senard J M; Bagheri H; Ferreira J; Rascol O; Lapeyre-Mestre M
Sleep attacks and antiparkinsonian drugs: a pilot prospective pharmacoepidemiologic study.
Clinical neuropharmacology 2001;24(3):181-3.
2001: Descombes S; Bonnet A M; Gasser U E; Thalamas C; Dingemanse J; Arnulf I; Bareille M P; Agid Y; Rascol O
Dual-release formulation, a novel principle in L-dopa treatment of Parkinson's disease.
Neurology 2001;56(9):1239-42.
2001: Loubinoux I; Carel C; Alary F; Boulanouar K; Viallard G; Manelfe C; Rascol O; Celsis P; Chollet F
Within-session and between-session reproducibility of cerebral sensorimotor activation: a test--retest effect evidenced with functional magnetic resonance imaging.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 2001;21(5):592-607.
2001: Descombes S; Brefel-Courbon C; Thalamas C; Albucher J F; Rascol O; Montastruc J L; Senard J M
Amitriptyline treatment in chronic drug-induced headache: a double-blind comparative pilot study.
Headache 2001;41(2):178-82.
2001: Rascol O; Nutt J G; Blin O; Goetz C G; Trugman J M; Soubrouillard C; Carter J H; Currie L J; Fabre N; Thalamas C; Giardina W W; Wright S
Induction by dopamine D1 receptor agonist ABT-431 of dyskinesia similar to levodopa in patients with Parkinson disease.
Archives of neurology 2001;58(2):249-54.
2001: Rascol O; Ferreira J J; Thalamas C; Galitsky M; Montastruc J L
Dopamine agonists. Their role in the management of Parkinson's disease.
Advances in neurology 2001;86():301-9.
2001: Senard J M; Brefel-Courbon C; Rascol O; Montastruc J L
Orthostatic hypotension in patients with Parkinson's disease: pathophysiology and management.
Drugs & aging 2001;18(7):495-505.
2001: Rascol O; Fabre N; Brefel-Courbon C; Montastruc J L
The pharmacologic treatment of gait ignition failure.
Advances in neurology 2001;87():255-64.
2000: Brefel-Courbon C; Thalamas C; Rascol O; Montastruc J L; Senard J M
Lack of autonomic nervous dysfunction in progressive supranuclear palsy, a study of blood pressure variability.
Clinical autonomic research : official journal of the Clinical Autonomic Research Society 2000;10(5):309-12.
2000: Olanow W; Schapira A H; Rascol O
Continuous dopamine-receptor stimulation in early Parkinson's disease.
Trends in neurosciences 2000;23(10 Suppl):S117-26.
2000: Montastruc J L; Chaumerliac C; Desboeuf K; Manika M; Bagheri H; Rascol O; Lapeyre-Mestre M
Adverse drug reactions to selegiline: a review of the French pharmacovigilance database.
Clinical neuropharmacology 2000;23(5):271-5.
2000: Ferreira J J; Rascol O
Prevention and therapeutic strategies for levodopa-induced dyskinesias in Parkinson's disease.
Current opinion in neurology 2000;13(4):431-6.
2000: Brefel-Courbon C; Simonetta-Moreau M; Moré C; Rascol O; Clanet M; Montastruc J L; Lapeyre-Mestre M
A pharmacoeconomic evaluation of botulinum toxin in the treatment of spasmodic torticollis.
Clinical neuropharmacology 2000;23(4):203-7.
2000: Herman-Bert A; Stevanin G; Netter J C; Rascol O; Brassat D; Calvas P; Camuzat A; Yuan Q; Schalling M; Dürr A; Brice A
Mapping of spinocerebellar ataxia 13 to chromosome 19q13.3-q13.4 in a family with autosomal dominant cerebellar ataxia and mental retardation.
American journal of human genetics 2000;67(1):229-35.
2000: Rascol O; Brooks D J; Korczyn A D; De Deyn P P; Clarke C E; Lang A E
A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa. 056 Study Group.
The New England journal of medicine 2000;342(20):1484-91.
2000: Rascol O
The pharmacological therapeutic management of levodopa-induced dyskinesias in patients with Parkinson's disease.
Journal of neurology 2000;247 Suppl 2():II51-7.
2000: Ferreira J J; Galitzky M; Montastruc J L; Rascol O
Sleep attacks and Parkinson's disease treatment.
Lancet 2000;355(9212):1333-4.
2000: Rascol O
Medical treatment of levodopa-induced dyskinesias.
Annals of neurology 2000;47(4 Suppl 1):S179-88.
2000: Carel C; Loubinoux I; Boulanouar K; Manelfe C; Rascol O; Celsis P; Chollet F
Neural substrate for the effects of passive training on sensorimotor cortical representation: a study with functional magnetic resonance imaging in healthy subjects.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 2000;20(3):478-84.
2000: Masson G S; Mestre D R; Martineau F; Soubrouillard C; Brefel C; Rascol O; Blin O
Lorazepam-induced modifications of saccadic and smooth-pursuit eye movements in humans: attentional and motor factors.
Behavioural brain research 2000;108(2):169-80.
2000: Malecaze F A; Deneuville S F; Julia B J; Daurin J G; Chapotot E M; Grandjean H M; Arné J L; Rascol O
Pain relief with intracameral mepivacaine during phacoemulsification.
The British journal of ophthalmology 2000;84(2):171-4.
2000: Sabatini U; Boulanouar K; Fabre N; Martin F; Carel C; Colonnese C; Bozzao L; Berry I; Montastruc J L; Chollet F; Rascol O
Cortical motor reorganization in akinetic patients with Parkinson's disease: a functional MRI study.
Brain : a journal of neurology 2000;123 ( Pt 2)():394-403.
2000: Delisle M B; Uro-Coste E; Murrell J R; Rascol O; Ghetti B
[Neurodegenerative disease associated with a mutation of codon 279 (N279K) in exon 10 of Tau protein]
Bulletin de l'Académie nationale de médecine 2000;184(4):799-809; discussion 809-11.
2000: Rascol O; Montastruc J L
[Role of dopaminergic agonists]
Revue neurologique 2000;156 Suppl 2 Pt 2():98-104.
1999: Loubinoux I; Boulanouar K; Ranjeva J P; Carel C; Berry I; Rascol O; Celsis P; Chollet F
Cerebral functional magnetic resonance imaging activation modulated by a single dose of the monoamine neurotransmission enhancers fluoxetine and fenozolone during hand sensorimotor tasks.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 1999;19(12):1365-75.
1999: Bezard E; Brefel C; Tison F; Peyro-Saint-Paul H; Ladure P; Rascol O; Gross C E
Effect of the alpha 2 adrenoreceptor antagonist, idazoxan, on motor disabilities in MPTP-treated monkey.
Progress in neuro-psychopharmacology & biological psychiatry 1999;23(7):1237-46.
1999: Montastruc J L; Rascol O; Senard J M
Treatment of Parkinson's disease should begin with a dopamine agonist.
Movement disorders : official journal of the Movement Disorder Society 1999;14(5):725-30.
1999: Pelat M; Lazartigues E; Tran M A; Gharib C; Montastruc J L; Montastruc P; Rascol O
Characterization of the central muscarinic cholinoceptors involved in the cholinergic pressor response in anesthetized dogs.
European journal of pharmacology 1999;379(2-3):117-24.
1999: Lazartigues E; Brefel-Courbon C; Tran M A; Montastruc J L; Rascol O
Spontaneously hypertensive rats cholinergic hyper-responsiveness: central and peripheral pharmacological mechanisms.
British journal of pharmacology 1999;127(7):1657-65.
1999: Bagheri H; Damase-Michel C; Lapeyre-Mestre M; Cismondo S; O'Connell D; Senard J M; Rascol O; Montastruc J L
A study of salivary secretion in Parkinson's disease.
Clinical neuropharmacology 1999;22(4):213-5.
1999: Delisle M B; Murrell J R; Richardson R; Trofatter J A; Rascol O; Soulages X; Mohr M; Calvas P; Ghetti B
A mutation at codon 279 (N279K) in exon 10 of the Tau gene causes a tauopathy with dementia and supranuclear palsy.
Acta neuropathologica 1999;98(1):62-77.
1999: Thalamas C; Taylor A; Brefel-Courbon C; Eagle S; Fitzpatrick K; Rascol O
Lack of pharmacokinetic interaction between ropinirole and theophylline in patients with Parkinson's disease.
European journal of clinical pharmacology 1999;55(4):299-303.
1999: Rascol O; Blin O; Thalamas C; Descombes S; Soubrouillard C; Azulay P; Fabre N; Viallet F; Lafnitzegger K; Wright S; Carter J H; Nutt J G
ABT-431, a D1 receptor agonist prodrug, has efficacy in Parkinson's disease.
Annals of neurology 1999;45(6):736-41.
1999: Montastruc J L; Ziegler M; Rascol O; Malbezin M
A randomized, double-blind study of a skin patch of a dopaminergic agonist, piribedil, in Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 1999;14(2):336-41.
1999: Rascol O
[Arguments in favor of early treatment of Parkinson's disease with dopaminergic agonists]
Revue neurologique 1999;155(1):35-42.
1999: Andreu N; Chalé J J; Senard J M; Thalamas C; Montastruc J L; Rascol O
L-Dopa-induced sedation: a double-blind cross-over controlled study versus triazolam and placebo in healthy volunteers.
Clinical neuropharmacology 1999;22(1):15-23.
1999: Rascol O
L-dopa-induced peak-dose dyskinesias in patients with Parkinson's disease: a clinical pharmacologic approach.
Movement disorders : official journal of the Movement Disorder Society 1999;14 Suppl 1():19-32.
1999: Rascol O; Brefel-Courbon C; Descombes S; Montastruc J L
Clinical pharmacology of levodopa-induced dyskinesia in parkinsonian patients.
Advances in neurology 1999;80():485-90.
1999: Rascol O
Dopamine agonists: what is the place of the newer compounds in the treatment of Parkinson's disease?
Journal of neural transmission. Supplementum 1999;55():33-45.
1998: Lazartigues E; Freslon J L; Tellioglu T; Brefel-Courbon C; Pelat M; Tran M A; Montastruc J L; Rascol O
Pressor and bradycardic effects of tacrine and other acetylcholinesterase inhibitors in the rat.
European journal of pharmacology 1998;361(1):61-71.
1998: Fabre N; Brefel C; Sabatini U; Celsis P; Montastruc J L; Chollet F; Rascol O
Normal frontal perfusion in patients with frozen gait.
Movement disorders : official journal of the Movement Disorder Society 1998;13(4):677-83.
1998: Rascol O; Sieradzan K; Peyro-Saint-Paul H; Thalamas C; Brefel-Courbon C; Senard J M; Ladure P; Montastruc J L; Lees A
Efaroxan, an alpha-2 antagonist, in the treatment of progressive supranuclear palsy.
Movement disorders : official journal of the Movement Disorder Society 1998;13(4):673-6.
1998: Allal C; Lazartigues E; Tran M A; Brefel-Courbon C; Gharib C; Montastruc J L; Rascol O
Central cardiovascular effects of tacrine in the conscious dog: a role for catecholamines and vasopressin release.
European journal of pharmacology 1998;348(2-3):191-8.
1998: Schrag A E; Brooks D J; Brunt E; Fuell D; Korczyn A; Poewe W; Quinn N P; Rascol O; Stocchi F
The safety of ropinirole, a selective nonergoline dopamine agonist, in patients with Parkinson's disease.
Clinical neuropharmacology 1998;21(3):169-75.
1998: Brefel C; Thalamas C; Rayet S; Lopez-Gil A; Fitzpatrick K; Bullman S; Citerone D R; Taylor A C; Montastruc J L; Rascol O
Effect of food on the pharmacokinetics of ropinirole in parkinsonian patients.
British journal of clinical pharmacology 1998;45(4):412-5.
1998: Brooks D J; Abbott R J; Lees A J; Martignoni E; Philcox D V; Rascol O; Roos R A; Sagar H J
A placebo-controlled evaluation of ropinirole, a novel D2 agonist, as sole dopaminergic therapy in Parkinson's disease.
Clinical neuropharmacology 1998;21(2):101-7.
1998: Rascol O; Sabatini U; Brefel C; Fabre N; Rai S; Senard J M; Celsis P; Viallard G; Montastruc J L; Chollet F
Cortical motor overactivation in parkinsonian patients with L-dopa-induced peak-dose dyskinesia.
Brain : a journal of neurology 1998;121 ( Pt 3)():527-33.
1998: Rascol O; Brefel-Courbon C; Blin O
[Clinical pharmacology of dyskinesias induced by L-dopa in Parkinsonian patients]
Thérapie 1998;53(1):43-8.
1998: Korczyn A D; Brooks D J; Brunt E R; Poewe W H; Rascol O; Stocchi F
Ropinirole versus bromocriptine in the treatment of early Parkinson's disease: a 6-month interim report of a 3-year study. 053 Study Group.
Movement disorders : official journal of the Movement Disorder Society 1998;13(1):46-51.
1998: Rascol O; Brooks D J; Brunt E R; Korczyn A D; Poewe W H; Stocchi F
Ropinirole in the treatment of early Parkinson's disease: a 6-month interim report of a 5-year levodopa-controlled study. 056 Study Group.
Movement disorders : official journal of the Movement Disorder Society 1998;13(1):39-45.
1998: Lazartigues E; Tran M A; Brefel-Courbon C; Montastruc J L; Rascol O
Endogenous central cholinergic systems and baroreflex modulation in the conscious dog.
Fundamental & clinical pharmacology 1998;12(6):643-5.
1998: Montastruc J L; Pelat M; Verwaerde P; Brefel-Courbon C; Tran M A; Blin O; Rascol O; Senard J M
Fluoxetine in orthostatic hypotension of Parkinson's disease: a clinical and experimental pilot study.
Fundamental & clinical pharmacology 1998;12(4):398-402.
1997: Soubrouillard C; Lombardo C; Rascol O; Bruguerolle B; Blin O
[Central dopaminergic D1 agonists and treatment of Parkinson disease]
Thérapie 1997;52(6):527-34.
1997: Senard J M; Raï S; Lapeyre-Mestre M; Brefel C; Rascol O; Rascol A; Montastruc J L
Prevalence of orthostatic hypotension in Parkinson's disease.
Journal of neurology, neurosurgery, and psychiatry 1997;63(5):584-9.
1997: Montastruc J L; Rascol O; Senard J M
Glutamate antagonists and Parkinson's disease: a review of clinical data.
Neuroscience and biobehavioral reviews 1997;21(4):477-80.
1997: Montastruc J L; Llau-Bousquet M E; Senard J M; Rascol O
[Movement disorders of drug origin]
La Revue du praticien 1997;47(10):1109-16.
1997: Fabre N; Brefel-Courbon C; Rascol O
[Parkinson "plus"]
La Revue du praticien 1997;47(10):1077-82.
1997: Andreu N; Damase-Michel C; Senard J M; Rascol O; Montastruc J L
A dose-ranging study of selegiline in patients with Parkinson's disease: effect of platelet monoamine oxidase activity.
Movement disorders : official journal of the Movement Disorder Society 1997;12(3):293-6.
1997: Rascol O; Sabatini U; Fabre N; Brefel C; Loubinoux I; Celsis P; Senard J M; Montastruc J L; Chollet F
The ipsilateral cerebellar hemisphere is overactive during hand movements in akinetic parkinsonian patients.
Brain : a journal of neurology 1997;120 ( Pt 1)():103-10.
1997: Rascol O; Fabre N; Sabatini U
[Functional imaging]
Neuro-Chirurgie 1997;43 Suppl 1():41-51.
1996: Llau M E; Durrieu G; Tran M A; Senard J M; Rascol O; Montastruc J L
A study of dopaminergic sensitivity in Parkinson's disease: comparison in "de novo" and levodopa-treated patients.
Clinical neuropharmacology 1996;19(5):420-7.
1996: Montastruc J L; Rascol O; Senard J M
New directions in the drug treatment of Parkinson's disease.
Drugs & aging 1996;9(3):169-84.
1996: Montastruc J L; Rascol O; Senard J M
The discovery of vasomotor nerves.
Clinical autonomic research : official journal of the Clinical Autonomic Research Society 1996;6(3):183-7.
1996: Rascol O; Lees A J; Senard J M; Pirtosek Z; Montastruc J L; Fuell D
Ropinirole in the treatment of levodopa-induced motor fluctuations in patients with Parkinson's disease.
Clinical neuropharmacology 1996;19(3):234-45.
1996: Montastruc J L; Llau M E; Senard J M; Tran M A; Rascol O; Montastruc P
A study of tolerance to apomorphine.
British journal of pharmacology 1996;117(5):781-6.
1996: Montastruc J L; Rascol O; Senard J M
Neuroprotection in Parkinson's disease.
Lancet 1996;347(8995):196.
1996: Rascol O; Allain H
Methodological aspects in assessing antidementia drugs.
Methods and findings in experimental and clinical pharmacology 1996;18 Suppl B():69-70.
1996: Rascol O; Lees A J; Senard J M; Pirtosek Z; Brefel C; Montastruc J L; Fuell D
A placebo-controlled study of ropinirole, a new D2 agonist, in the treatment of motor fluctuations of L-DOPA-treated parkinsonian patients.
Advances in neurology 1996;69():531-4.
1996: Montastruc J L; Senard J M; Rascol O; Rascol A
Autonomic nervous system dysfunction and adrenoceptor regulation in Parkinson's disease. Clinical and pharmacological consequences.
Advances in neurology 1996;69():377-81.
1995: Rascol O; Hain T C; Brefel C; Benazet M; Clanet M; Montastruc J L
Antivertigo medications and drug-induced vertigo. A pharmacological review.
Drugs 1995;50(5):777-91.
1995: Brefel C; Lazartigues E; Tran M A; Gauquelin G; Geelen G; Gharib C; Montastruc J L; Montastruc P; Rascol O
Central cardiovascular effects of acetylcholine in the conscious dog.
British journal of pharmacology 1995;116(4):2175-82.
1995: Llau M E; Senard J M; Rascol O; Montastruc J L
[Movement disorders induced by drugs: experience at a pharmaco-vigilance center over five years]
Thérapie 1995;50(5):425-7.
1995: Sénard J M; Verwaerde P; Rascol O; Montastruc J L
Effects of acute levodopa administration on blood pressure and heart variability in never treated parkinsonians.
Hypertension research : official journal of the Japanese Society of Hypertension 1995;18 Suppl 1():S175-7.
1995: Montastruc J L; Fabre N; Blin O; Senard J M; Rascol O; Rascol A
Does fluoxetine aggravate Parkinson's disease? A pilot prospective study.
Movement disorders : official journal of the Movement Disorder Society 1995;10(3):355-7.
1995: Rascol O; Sabatini U; Fabre N; Senard J M; Simonetta-Moreau M; Montastruc J L; Clanet M; Rascol A
Abnormal vestibuloocular reflex cancellation in multiple system atrophy and progressive supranuclear palsy but not in Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 1995;10(2):163-70.
1995: Montastruc J L; Rascol O; Senard J M; Houin G; Rascol A
Sublingual apomorphine: a new pharmacological approach in Parkinson's disease?
Journal of neural transmission. Supplementum 1995;45():157-61.
1995: Angibaud G; Moreau M S; Rascol O; Clanet M
Treatment of hemifacial spasm with botulinum toxin. Value of preinjection electromyography abnormalities for predicting postinjection lower facial paresis.
European neurology 1995;35(1):43-5.
1994: Montastruc J L; Lapeyre-Mestre M; Llau M E; Senard J M; Rascol O; Montastruc P
Naloxone does not prevent apomorphine-induced emesis or hypotension in dogs.
Clinical autonomic research : official journal of the Clinical Autonomic Research Society 1994;4(6):303-5.
1994: Pourrat J; Montastruc J L; Lacombe J L; Cisterne J M; Rascol O; Dumazer P
[Nephropathy associated with Chinese herbal drugs. 2 cases]
Presse médicale (Paris, France : 1983) 1994;23(36):1669.
1994: Blin O; Rascol O; Azulay J P; Serratrice G; Nieoullon A
A single report of hemiplegic arm stretching related to yawning: further investigation using apomorphine administration.
Journal of the neurological sciences 1994;126(2):225-7.
1994: Llau M E; Nguyen L; Senard J M; Rascol O; Montastruc J L
[Drug-induced parkinsonian syndromes: a 10-year experience at a regional center of pharmaco-vigilance]
Revue neurologique 1994;150(11):757-62.
1994: Montastruc J L; Rascol O; Senard J M; Rascol A
A randomised controlled study comparing bromocriptine to which levodopa was later added, with levodopa alone in previously untreated patients with Parkinson's disease: a five year follow up.
Journal of neurology, neurosurgery, and psychiatry 1994;57(9):1034-8.
1994: Llau M E; Nguyen L; Senard J M; Rascol O; Montastruc J L
[Drug-induced Parkinson syndrome: 10 years of drug vigilance]
Thérapie 1994;49(5):459-60.
1994: Blin O; Desnuelle C; Rascol O; Borg M; Peyro Saint Paul H; Azulay J P; Billé F; Figarella D; Coulom F; Pellissier J F
Mitochondrial respiratory failure in skeletal muscle from patients with Parkinson's disease and multiple system atrophy.
Journal of the neurological sciences 1994;125(1):95-101.
1994: Rascol O; Fabre N; Blin O; Poulik J; Sabatini U; Senard J M; Ané M; Montastruc J L; Rascol A
Naltrexone, an opiate antagonist, fails to modify motor symptoms in patients with Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 1994;9(4):437-40.
1994: Rascol O; Sabatini U; Chollet F; Fabre N; Senard J M; Montastruc J L; Celsis P; Marc-Vergnes J P; Rascol A
Normal activation of the supplementary motor area in patients with Parkinson's disease undergoing long-term treatment with levodopa.
Journal of neurology, neurosurgery, and psychiatry 1994;57(5):567-71.
1994: Démonet J F; Celsis P; Agniel A; Cardebat D; Rascol O; Marc-Vergnes J P
Activation of regional cerebral blood flow by a memorization task in early Parkinson's disease patients and normal subjects.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 1994;14(3):431-8.
1994: Montastruc J L; Fabre N; Rascol O; Senard J M; Blin O
N-methyl-D-aspartate (NMDA) antagonist and Parkinson's disease: a pilot study with dextromethorphan.
Movement disorders : official journal of the Movement Disorder Society 1994;9(2):242-3.
1994: Llau M E; Damase-Michel C; Lapeyre-Mestre M; Vie M; Rascol O
[Pharmacovigilance of antibiotics. Evaluation by the Midi-Pyrénées Pharmacovigilance Center between 1989 and 1992]
Thérapie 1994;49(2):123-7.
1994: Rascol O; Montastruc J L
[Drug therapy of vertigo]
La Revue du praticien 1994;44(3):354-60.
1994: Bagheri H; Berlan M; Senard J M; Rascol O; Montastruc J L
Lacrimation in Parkinson's disease.
Clinical neuropharmacology 1994;17(1):89-91.
1994: Pascali P; Sorbette F; Senard J M; Fabre N; Rascol O; Montastruc J L
[Apropos of secondary effects of hydroxyzine]
Thérapie 1994;49(1):56.
1994: Montastruc J L; Llau M E; Rascol O; Senard J M
Drug-induced parkinsonism: a review.
Fundamental & clinical pharmacology 1994;8(4):293-306.
1993: Montastruc J L; Rascol O; Senard J M
Current status of dopamine agonists in Parkinson's disease management.
Drugs 1993;46(3):384-93.
1993: Sabatini U; Chollet F; Rascol O; Celsis P; Rascol A; Lenzi G L; Marc-Vergnes J P
Effect of side and rate of stimulation on cerebral blood flow changes in motor areas during finger movements in humans.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 1993;13(4):639-45.
1993: Fabre N; Montastruc J L; Rascol O
Alopecia: an adverse effect of bromocriptine.
Clinical neuropharmacology 1993;16(3):266-8.
1993: Senard J M; Rascol O; Durrieu G; Tran M A; Berlan M; Rascol A; Montastruc J L
Effects of yohimbine on plasma catecholamine levels in orthostatic hypotension related to Parkinson disease or multiple system atrophy.
Clinical neuropharmacology 1993;16(1):70-6.
1993: Montastruc J L; Chamontin B; Senard J M; Tran M A; Rascol O; Llau M E; Rascol A
Pseudophaeochromocytoma in parkinsonian patient treated with fluoxetine plus selegiline.
Lancet 1993;341(8844):555.
1993: Rascol O J; Sabatini U; Chollet F; Montastruc J L; Marc-Vergnes J P; Rascol A
Impaired activity of the supplementary motor area in akinetic patients with Parkinson's disease. Improvement by the dopamine agonist apomorphine.
Advances in neurology 1993;60():419-21.
1993: Rascol O J; Clanet M; Senard J M; Montastruc J L; Rascol A
Vestibulo-ocular reflex in Parkinson's disease and multiple system atrophy.
Advances in neurology 1993;60():395-7.
1993: De Recondo A; Rondot P; Loc'h C; Crouzel C; Dao-Castellana M H; Bathien N G; Rascol O; Clanet M; De Recondo J; Samson Y
[Positron-emission tomographic study of the dopaminergic system in a case of secondary unilateral tremor after mesencephalic hematoma]
Revue neurologique 1993;149(1):46-9.
1993: Senard J M; Rascol O; Rascol A; Montastruc J L
Lack of yohimbine effect on ambulatory blood pressure recording: a double-blind cross-over trial in parkinsonians with orthostatic hypotension.
Fundamental & clinical pharmacology 1993;7(8):465-70.
1993: Senard J M; Rascol O; Chamontin B; Rascol A; Montastruc J L
[Ambulatory monitoring of blood pressure in orthostatic hypotension of Parkinson disease]
Revue neurologique 1993;149(10):541-6.
1992: Montastruc J L; Rascol O; Montastruc P
Naloxone or haloperidol but not yohimbine reverse apomorphine-induced respiratory depression.
Clinical neuropharmacology 1992;15(5):404-7.
1992: Kastner A; Hirsch E C; Lejeune O; Javoy-Agid F; Rascol O; Agid Y
Is the vulnerability of neurons in the substantia nigra of patients with Parkinson's disease related to their neuromelanin content?
Journal of neurochemistry 1992;59(3):1080-9.
1992: Lapeyre-Mestre M; Chave B; Rascol O; Senard J M; Lafont J; Montastruc J L
[Antiparkinsonian drug consumption in a University Hospital Center 1981-1990]
Thérapie 1992;47(5):444-5.
1992: Montastruc J L; Rascol O; Senard J M; Rascol A
A pilot study of N-methyl-D-aspartate (NMDA) antagonist in Parkinson's disease.
Journal of neurology, neurosurgery, and psychiatry 1992;55(7):630-1.
1992: Potier B; Rascol O; Jazat F; Lamour Y; Dutar P
Alterations in the properties of hippocampal pyramidal neurons in the aged rat.
Neuroscience 1992;48(4):793-806.
1992: Durrieu G; LLau M E; Rascol O; Senard J M; Rascol A; Montastruc J L
Parkinson's disease and weight loss: a study with anthropometric and nutritional assessment.
Clinical autonomic research : official journal of the Clinical Autonomic Research Society 1992;2(3):153-7.
1992: Rascol O; Sabatini U; Chollet F; Celsis P; Montastruc J L; Marc-Vergnes J P; Rascol A
Supplementary and primary sensory motor area activity in Parkinson's disease. Regional cerebral blood flow changes during finger movements and effects of apomorphine.
Archives of neurology 1992;49(2):144-8.
1991: Sié P; Camez A; Derobert E; Rascol O; Montastruc J L; Boneu B
Locally activated coagulation induced by a peripheral endovenous catheter.
Thrombosis research 1991;64(6):775-82.
1991: Montastruc J L; Rascol O; Senard J M; Gualano V; Bagheri H; Houin G; Lees A; Rascol A
Sublingual apomorphine in Parkinson's disease: a clinical and pharmacokinetic study.
Clinical neuropharmacology 1991;14(5):432-7.
1991: Agniel A; Celsis P; Viallard G; Montastruc J L; Rascol O; Demonet J F; Marc-Vergnes J P; Rascol A
Cognition and cerebral blood flow in lateralised parkinsonism: lack of functional lateral asymmetries.
Journal of neurology, neurosurgery, and psychiatry 1991;54(9):783-6.
1991: Sabatini U; Rascol O; Celsis P; Houin G; Rascol A; Marc-Vergnes J P; Montastruc J L
Subcutaneous apomorphine increases regional cerebral blood flow in parkinsonian patients via peripheral mechanisms.
British journal of clinical pharmacology 1991;32(2):229-34.
1991: Rascol O; Sabatini U; Simonetta-Moreau M; Montastruc J L; Rascol A; Clanet M
Square wave jerks in parkinsonian syndromes.
Journal of neurology, neurosurgery, and psychiatry 1991;54(7):599-602.
1991: Simonetta M; Clanet M; Rascol O
Bereitschaftspotential in a simple movement or in a motor sequence starting with the same simple movement.
Electroencephalography and clinical neurophysiology 1991;81(2):129-34.
1991: Rascol O; Potier B; Lamour Y; Dutar P
Effects of calcium channel agonist and antagonists on calcium-dependent events in CA1 hippocampal neurons.
Fundamental & clinical pharmacology 1991;5(4):299-317.
1990: Rascol O; Fabre N; Teräväinen H; Poewe W; Lücking C; Rinne U; Dupont E; Hirt D; Hoyer M; Lataste X
CQA 206-291: a novel dopamine agonist in the treatment of Parkinson's disease.
Clinical neuropharmacology 1990;13(4):303-11.
1990: Rascol O; Senard J M; Rascol A; Montastruc J L
Apomorphine test in parkinsonian syndromes.
Lancet 1990;336(8713):518.
1990: Rascol O; Montastruc J L; Gauquelin G; Tran M A; Geelen G; Gharib C; Montastruc P
Cardiovascular effects of central injection of acetylcholine in anaesthetized dogs: a role for vasopressin release.
British journal of pharmacology 1990;100(3):471-6.
1990: Sabatini U; Rascol O; Rascol A; Montastruc J L
Migraine attacks induced by subcutaneous apomorphine in two migrainous parkinsonian patients.
Clinical neuropharmacology 1990;13(3):264-7.
1990: Durrieu G; Senard J M; Rascol O; Tran M A; Lataste X; Rascol A; Montastruc J L
Blood pressure and plasma catecholamines in never-treated parkinsonian patients: effect of a selective D1 agonist (CY 208-243).
Neurology 1990;40(4):707-9.
1990: Rascol O; Salachas F; Montastruc J L
[Neuroleptic malignant-like syndrome following levodopa withdrawal]
Revue neurologique 1990;146(3):215-8.
1990: Montastruc J L; Rascol O; Rascol A
[Comparison of bromocriptine and levodopa as first line treatment of Parkinson's disease: results of a 3-year prospective randomized study]
Revue neurologique 1990;146(2):144-7.
1990: Potier B; Rascol O; Lamour Y; Dutar P
[Effect of verapamil independent of its calcium channel antagonist action on hippocampal pyramidal neurons in rats]
Comptes rendus de l'Académie des sciences. Série III, Sciences de la vie 1990;311(2):89-94.
1989: Lees A J; Montastruc J L; Turjanski N; Rascol O; Kleedorfer B; Peyro Saint-Paul H; Stern G M; Rascol A
Sublingual apomorphine and Parkinson's disease.
Journal of neurology, neurosurgery, and psychiatry 1989;52(12):1440.
1989: Dutar P; Rascol O; Lamour Y
Omega-conotoxin GVIA blocks synaptic transmission in the CA1 field of the hippocampus.
European journal of pharmacology 1989;174(2-3):261-6.
1989: Fabre F; Rascol O; Didier A; Testut M F; Delisle M B; Leophonte P
[Prolongation of distal (D.L.) and proximal (P.L.) latencies in the sciatic nerve of the rat after hymenoptera venom injection]
Journal de toxicologie clinique et expérimentale 1989;9(6):423-5.
1989: Rascol O; Clanet M; Montastruc J L; Simonetta M; Soulier-Esteve M J; Doyon B; Rascol A
Abnormal ocular movements in Parkinson's disease. Evidence for involvement of dopaminergic systems.
Brain : a journal of neurology 1989;112 ( Pt 5)():1193-214.
1989: Celsis P; Montastruc J L; Rascol O; Senard J M; Marc-Vergnes J P; Rascol A
Effect of tropatepine, an anticholinergic drug, on regional cerebral blood flow in patients with Parkinson's disease.
Journal of neurology, neurosurgery, and psychiatry 1989;52(7):917-8.
1989: Montastruc J L; Rascol O; Rascol A
A randomised controlled study of bromocriptine versus levodopa in previously untreated Parkinsonian patients: a 3 year follow-up.
Journal of neurology, neurosurgery, and psychiatry 1989;52(6):773-5.
1989: Berlan M; Rascol O; Belin J; Moatti J P; Rascol A; Montastruc J L
Alpha 2-adrenergic sensitivity in Parkinson's disease.
Clinical neuropharmacology 1989;12(2):138-44.
1989: Rascol O; Dutar P; Lamour Y
Involvement of a pertussis toxin-sensitive G-protein in the pharmacological properties of septo-hippocampal neurones.
British journal of pharmacology 1989;96(4):956-60.
1989: Rascol O; Squalli A; Montastruc J L; Garat A; Houin G; Lachau S; Tor J; Blehaut H; Rascol A
A pilot study of stiripentol, a new anticonvulsant drug, in complex partial seizures uncontrolled by carbamazepine.
Clinical neuropharmacology 1989;12(2):119-23.
1989: Rascol A; Montastruc J L; Rascol O
[Antiparkinsonian drugs]
La Revue du praticien 1989;39(8):663-9.
1989: Dutar P; Rascol O; Lamour Y
Rhythmical bursting activity and GABAergic mechanisms in the medial septum of normal and pertussis toxin-pretreated rats.
Experimental brain research. Experimentelle Hirnforschung. Expérimentation cérébrale 1989;77(2):374-80.
1989: Rascol O; Clanet M; Montastruc J L
Calcium antagonists and the vestibular system: a critical review of flunarizine as an antivertigo drug.
Fundamental & clinical pharmacology 1989;3 Suppl():79s-87s.
1989: Montastruc J L; Gaillard G; Rascol O; Tran M A; Montastruc P
Effect of apomorphine on adrenal medullary catecholamine levels.
Fundamental & clinical pharmacology 1989;3(6):665-70.
1989: Clanet M; Blancher A; Calvas P; Rascol O
Interferons and multiple sclerosis.
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 1989;43(5):355-60.
1988: Montastruc J L; Rascol O; Rascol A
[Bromocriptine versus levodopa in the early treatment of Parkinson's disease. 1st results after 2 years]
Thérapie 1988;43(6):461-3.
1988: Rascol O; Montastruc J L; Senard J M; Demonet J F; Simonetta M; Rascol A
Two weeks of treatment with deprenyl (selegiline) does not prolong L-dopa effect in parkinsonian patients: a double-blind cross-over placebo-controlled trial.
Neurology 1988;38(9):1387-91.
1988: Cervera P; Rascol O; Ploska A; Gaillard G; Raisman R; Duyckaerts C; Hauw J J; Scherman D; Montastruc J L; Javoy-Agid F
Noradrenaline, adrenaline and tyrosine hydroxylase in adrenal medulla from parkinsonian patients.
Journal of neurology, neurosurgery, and psychiatry 1988;51(8):1104-5.
1988: Rascol O; Lamour Y
Differential effects of M1 and M2 muscarinic drugs on septohippocampal, hippocampal and cortical neurons in the rat.
Brain research 1988;446(2):303-13.
1988: Marc-Vergnes J P; Celsis P; Montastruc J L; Demonet J F; Agniel A; Rascol O; Viallard G; Doyon B; Rascol A
[Cerebral hemodynamics and clinical pharmacology in Parkinson disease]
Thérapie 1988;43(2):83-8.
1988: Tran M A; De Saint-Blanquat G; Valet P; Tran L D; Anglade F; Gaillard G; Rascol O; Brisac A M; Montastruc J L; Montastruc P
Is adrenal medulla involved in the antihypertensive effect of nicardipine?
The Journal of pharmacology and experimental therapeutics 1988;244(3):1116-20.
1988: Celsis P; Rascol O; Demonet J F; Agniel A; Montastruc J L; Marc-Vergnes J P; Rascol A
[Effect of bromocriptine on cerebral blood flow in Parkinson's disease]
Revue neurologique 1988;144(5):367-71.
1987: Rascol O; Tran M A; Bonnevialle P; Belin J; Cotonat J; Guiraud-Chaumeil B; Montastruc J L
Lack of correlation between plasma levels of amitriptyline (and nortriptyline) and clinical improvement of chronic pain of peripheral neurologic origin.
Clinical neuropharmacology 1987;10(6):560-4.
1987: Gaillard G; Rascol O; Montastruc J L
Adrenal catecholamine concentration after domperidone.
Clinical neuropharmacology 1987;10(5):479-81.
1987: Montastruc J L; Rascol O; Belin J; Ane M; Rascol A
Does papaverine interact with levodopa in Parkinson's disease?
Annals of neurology 1987;22(4):558-9.
1987: Dutar P; Rascol O; Jobert A; Lamour Y
Modulation of the excitability of septohippocampal terminals in the rat: relation to neuronal discharge rate.
Brain research 1987;418(1):98-110.
1987: Montastruc J L; Chamontin B; Rostin M; Rascol O; Valet P; Gaillard G; Tran M A; Van T T; Ader J L; Montastruc P
Experimental and clinical approaches to treatment of hypertension by dopamine receptor agonists.
Clinical and experimental hypertension. Part A, Theory and practice 1987;9(5-6):1069-84.
1986: Lamour Y; Dutar P; Rascol O; Jobert A
Septohippocampal neurons after intraventricular AF64A administration in rats: an electrophysiological study.
Experimental neurology 1986;92(2):413-20.
1986: Rascol A; Montastruc J L; Rascol O
Flunarizine versus pizotifen: a double-blind study in the prophylaxis of migraine.
Headache 1986;26(2):83-5.
1986: Dutar P; Lamour Y; Rascol O; Jobert A
Septo-hippocampal neurons in the rat: further study of their physiological and pharmacological properties.
Brain research 1986;365(2):325-34.
1986: Dutar P; Rascol O; Jobert A; Lamour Y
Comparison of septo-hippocampal with basalo-cortical projection neurons in the rat: an electrophysiological approach.
Neuroscience letters 1986;63(1):86-90.
1986: Lamour Y; Dutar P; Rascol O; Jobert A
Basal forebrain neurons projecting to the rat frontoparietal cortex: electrophysiological and pharmacological properties.
Brain research 1986;362(1):122-31.
1986: Rascol O J; Montastruc J L
Cardiovascular effects of apomorphine in humans: evidence for peripheral mechanisms.
Clinical neuropharmacology 1986;9(6):566-9.
1986: Rascol A; Montastruc J L; Rascol O; Senard J M
Mesulergine (CU 32-085) in the treatment of Parkinson's disease.
Clinical neuropharmacology 1986;9(2):146-52.
1986: Rascol O; Dutar P; Jobert A; Lamour Y
[Excitability of septo-hippocampal axon terminals: changes as a function of the level of neuronal activity]
Comptes rendus de l'Académie des sciences. Série III, Sciences de la vie 1986;302(1):33-6.
1985: Rascol O; Clanet M; Venisse T; Soulier M J; Fraysse B
[Ocular motility and the cerebellum]
Journal français d'ophtalmologie 1985;8(1):73-84.
1984: Rascol A; Montastruc J L; Rascol O
Should dopamine agonists be given early or late in the treatment of Parkinson's disease?
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1984;11(1 Suppl):229-32.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Olivier Rascol

Research Profile (preview)

Disorders

Chemicals & Drugs

Procedures

Concepts & Ideas

Anatomy

Living Beings

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Olivier Rascol (preview)

All Publications